Sphera Funds Management Ltd. Gilead Sciences, Inc. Transaction History

Sphera Funds Management Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.47 Million - $1.66 Million	-20,000 Reduced 50.0%	20,000 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $3.04 Million - $3.47 Million	40,000 New	40,000 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $6.26 Million - $7.15 Million	105,090 New	105,090 $6.48 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $14.1 Million - $15.5 Million	225,000 Added 46.88%	705,000 $44.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $8.13 Million - $9.11 Million	130,000 Added 37.14%	480,000 $31.2 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $4.24 Million - $5.53 Million	-70,000 Reduced 16.67%	350,000 $21.9 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $4.63 Million - $5.13 Million	65,000 Added 18.31%	420,000 $32.4 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $23 Million - $26.9 Million	355,000 New	355,000 $25.1 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $16.4 Million - $19.2 Million	-230,000 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $16.6 Million - $19.7 Million	230,000	230,000 $18.6 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.